Quarterly Results

HINDUSTAN BIO SCIENCES LTD.

NSE : NABSE : 532041ISIN CODE : INE597C01021Industry : Pharmaceuticals & DrugsHouse : Private
BSE7.25-0.14 (-1.89 %)
PREV CLOSE ( ) 7.39
OPEN PRICE ( ) 7.39
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 14837
TODAY'S LOW / HIGH ( )7.25 7.39
52 WK LOW / HIGH ( ) 5.1515.18
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
3.22
3.17
NA
3.33
Total Expenditure
2.65
2.59
1.2
3.13
PBIDT (Excl OI)
0.57
0.58
-1.2
0.2
Other Income
0.15
0.1
NA
NA
Operating Profit
0.72
0.68
-1.2
0.2
Interest
0.01
0.01
0.01
0.02
Exceptional Items
NA
NA
NA
NA
PBDT
0.71
0.67
-1.21
0.18
Depreciation
0.01
0.01
0.01
0.02
Profit Before Tax
0.7
0.66
-1.22
0.16
Tax
NA
NA
NA
0.02
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
0.7
0.66
-1.22
0.14
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
0.7
0.66
-1.22
0.14
Equity Capital
20.5
20.5
20.5
20.5
Face Value (IN RS)
2
2
2
2
Reserves
Calculated EPS
0.06
0.06
-0.11
0.01
Calculated EPS (Annualised)
0.27
0.25
-0.47
0.05
No of Public Share Holdings
9001194
9001194
9001194
9001194
% of Public Share Holdings
87.81
87.81
87.81
87.81
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
17.70
18.29
NA
6.00
PBIDTM%
22.36
21.45
NA
6.00
PBDTM%
22.04
21.13
NA
5.40
PBTM%
21.73
20.82
NA
4.80
PATM%
21.73
20.82
NA
4.20
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.